Home › Stocks › OCDX › All Fund Holders
OCDX — ORTHO CLINICAL DIAGNOSTICS H · All Fund Holders
Funds holding (latest): 37 · Reported value held: $1.15B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| T. Rowe Price Associates history | Q1 2022 | 19.49M | $363.67M | 0.04% | Reduce |
| Vanguard Group history | Q1 2022 | 11.05M | $206.14M | 0.01% | Hold |
| JPMorgan Chase & Co history | Q1 2022 | 8.54M | $159.41M | 0.04% | Add |
| Janus Henderson Group history | Q1 2022 | 4.48M | $83.53M | 0.04% | Reduce |
| Lazard Asset Management history | Q1 2022 | 3.33M | $62.05M | 0.08% | Reduce |
| Goldman Sachs Group history | Q1 2022 | 2.19M | $40.89M | 0.01% | Add |
| Geode Capital Management history | Q1 2022 | 2.14M | $39.93M | 0.01% | Reduce |
| Deutsche Bank AG history | Q1 2022 | 1.63M | $30.48M | 0.01% | Add |
| Balyasny Asset Management history | Q1 2022 | 1.13M | $21.11M | 0.07% | Reduce |
| Northern Trust Corp history | Q1 2022 | 1.09M | $20.41M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q1 2022 | 888.45K | $16.58M | 0.01% | Add |
| Citigroup Inc history | Q1 2022 | 887.57K | $16.56M | 0.01% | Add |
| Millennium Management history | Q1 2022 | 518.27K | $9.67M | 0.01% | Add |
| Royce & Associates history | Q4 2021 | 449.17K | $9.61M | 0.07% | Reduce |
| BNY Mellon history | Q1 2022 | 493.45K | $9.21M | 0.00% | Add |
| UBS Group AG history | Q1 2022 | 426.88K | $7.97M | 0.00% | Add |
| Point72 Asset Management history | Q1 2022 | 400.00K | $7.46M | 0.03% | Add |
| Arrowstreet Capital history | Q1 2022 | 333.61K | $6.22M | 0.01% | Add |
| Renaissance Technologies history | Q1 2022 | 306.60K | $5.72M | 0.01% | Add |
| Prudential Financial history | Q4 2021 | 255.73K | $5.47M | 0.01% | Reduce |
| Citadel Advisors history | Q1 2022 | 259.45K | $4.84M | 0.00% | Add |
| Manulife Financial history | Q1 2022 | 226.81K | $4.23M | 0.00% | Add |
| Bank of America Corp history | Q1 2022 | 224.24K | $4.18M | 0.00% | Add |
| Morgan Stanley history | Q1 2022 | 177.66K | $3.32M | 0.00% | Reduce |
| Invesco Ltd history | Q1 2022 | 148.01K | $2.76M | 0.00% | Add |
| Wells Fargo & Co history | Q1 2022 | 129.69K | $2.42M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q1 2022 | 109.44K | $2.04M | 0.00% | Hold |
| First Eagle Investment Management history | Q1 2022 | 94.74K | $1.77M | 0.00% | Add |
| Marshall Wace history | Q1 2022 | 92.39K | $1.73M | 0.00% | Add |
| MFS Investment Management history | Q4 2021 | 56.19K | $1.20M | 0.00% | New |
| Two Sigma Investments history | Q1 2022 | 64.31K | $1.20M | 0.00% | Reduce |
| Wellington Management Group history | Q1 2022 | 49.54K | $924.00K | 0.00% | Add |
| Bridgewater Associates history | Q1 2022 | 28.54K | $533.00K | 0.00% | New |
| Principal Global Investors history | Q1 2022 | 21.87K | $408.00K | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2022 | 18.34K | $342.00K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q1 2022 | 744 | $14.00K | 0.00% | New |
| PNC Financial Services history | Q1 2022 | 608 | $11.00K | 0.00% | Reduce |